Twitter

Archive for June 2nd, 2012


Infomation Regarding Melanoma

Melanoma is a dangerous type of skin cancer. The cause of it is a change to the melanocyte cells. Melanin is created from a pigment in these cell. Melanin gives colour to your hair and skin. Melanin can start anywhere on the skin, including on existing moles. A mole you’re had from birth may later [...]

Read More...

Ovarian Cancer, Leukemia, Kidney Cancer, Melanoma, Lung Cancer 2012 ASCO Annual Meeting Highlights

Dr. Carol Aghajanian discusses cancer research news highlighted at ASCO’s 2012 Annual Meeting that covers research on ovarian cancer treatment, acute lymphoblastic leukemia in adolescents and young adults, kidney cancer treatment choices, and a new targeted treatment for melanoma, kidney cancer, and non-small cell lung cancer. For more information, visit Cancer.Net (www.cancer.net).

Read More...

Early cervical cancer diagnosis key to survival

Dr. Angela Marshall, director of Comprehensive Women’s Health in Silver Spring, MD, discusses the importance of early detection to prevent cervical cancer and the use of the HPV vaccine.

Read More...

ASCO ’12: J&J Scores Big With Prostate Cancer Pill

Zytiga improved survival in “pre-chemo” prostate cancer patients by 33% and more than doubled the time before cancer worsened compared to control, according to results from a phase III study to be presented today at the American Society of Clinical Oncology annual meeting.

Read More...

Avastin delays progression of ovarian cancer

Adding cancer drug Avastin to standard chemotherapy doubled the length of time a certain group of advanced ovarian cancer patients lived without their disease getting worse, according to results of a clinical trial.

Read More...

Immune boosters show promise against cancer

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Read More...

Hope For Late-Stage Lung Cancer? Two-Drug Combo Activates Genes That Help Tumors Self-Destruct

Researchers from Case Western Reserve University School of Medicine and Mount Sinai School of Medicine found that the anti-psychotic medication trifluoperazine can reactivate a gene pathway involved in tumor suppression that’s normally turned off in lung cancer patients.

Read More...

UC Davis researchers identify new biomarkers, therapeutic targets for kidney cancer

Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.

Read More...

Dana-Farber/Children’s Hospital Cancer Center devise new strategy that directly activates cellular ‘death protein’

Researchers at Dana-Farber/Children’s Hospital Cancer Center have devised a strategy to directly activate a natural “death” protein, triggering the self-destruction of cells. They say the development could represent a new paradigm for designing cancer drugs.

Read More...

UCLA researchers report for the first time how cells communicate to activate Notch signaling

During formation of multi-cellular organisms, cells need to talk to each other to make critical decisions as to what kind of cell to become, as well as when and where to become that cell type. The Notch signaling system allows cells to directly talk to each other to program almost every cell type in the body. Now, researchers from UCLA’s Jonsson Comprehensive Cancer Center have shown for the first time that the mechanical force produced by cell-cell interactions is critical for programming by the Notch signaling system.

Read More...